J
Jin Medical International Ltd
NASDAQ:ZJYL
Jin Medical International Ltd
NASDAQ:ZJYL
Price:
2.08
USD
4%
Market Cap:
$16.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
Jin Medical International Ltd
NASDAQ:ZJYL
|
CN |
|
Parag Milk Foods Ltd
NSE:PARAGMILK
|
IN |
|
Shandong Rike Chemical Co Ltd
SZSE:300214
|
CN |
Income Statement
Earnings Waterfall
Jin Medical International Ltd
Jin Medical International Ltd
Income Statement
Jin Medical International Ltd
Jin Medical International Ltd
Currency: USD
| Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
29
N/A
|
20
-33%
|
20
+2%
|
24
+17%
|
23
-3%
|
21
-9%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(20)
|
(13)
|
(13)
|
(14)
|
(15)
|
(15)
|
|
| Gross Profit |
10
N/A
|
7
-30%
|
7
+3%
|
10
+36%
|
8
-14%
|
6
-26%
|
|
| Operating Income | |||||||
| Operating Expenses |
(6)
|
(4)
|
(5)
|
(6)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(3)
|
(2)
|
(3)
|
(4)
|
(5)
|
(4)
|
|
| Research & Development |
(3)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
|
| Operating Income |
4
N/A
|
3
-27%
|
2
-19%
|
4
+57%
|
2
-46%
|
1
-69%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
0
|
0
|
1
|
0
|
0
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
5
N/A
|
3
-32%
|
3
+1%
|
4
+28%
|
2
-47%
|
2
-27%
|
|
| Net Income | |||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
4
|
3
|
3
|
3
|
2
|
1
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Income (Common) |
4
N/A
|
3
-36%
|
3
+1%
|
4
+26%
|
2
-51%
|
1
-34%
|
|
| EPS (Diluted) |
0.66
N/A
|
0.39
-41%
|
0.37
-5%
|
0.47
+27%
|
0.23
-51%
|
0.15
-35%
|
|
Switch to:
Switch to:
See Also
Discover More
